Wednesday, July 21, 2010

Researchers Block Pathway That Performs Key Function In End-Stage Prostate Cancer

Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens.

Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth.

Read more at Medical News Today.

No comments: